Be in the know. 15 key reads for Friday…

  1. F.D.A. Approves Gilead’s Remdesivir as First Drug to Treat Covid-19 (New York Times)
  2. Wells Fargo Is Said to Discuss Sale of Its Asset-Management Arm (Bloomberg)
  3. Pelosi-Mnuchin Talks Drag, Likely Pushing Stimulus Past Election (Bloomberg)
  4. Intel Beat Earnings Expectations. Why Its Stock Is Tumbling. (Barron’s)
  5. Trump Seizes On Biden Oil Comment to Warn Swing State Voters (Bloomberg)
  6. China Economic Rebound Pushes Copper Prices to Multiyear High (Wall Street Journal)
  7. UK retail sales rise at record pace in 3rd quarter, as Brits splash out on clothes, shoes and dining out (Business Insider)
  8. Warren Buffett’s great-nephew joins the SPAC boom by listing a $150 million blank-check company (Business Insider)
  9. GE stock price target raised to $9.00 from $8.50 at UBS (MarketWatch)
  10. Why Goldman Sachs sees a 2021 bull market brewing for commodities (MarketWatch)
  11. These are the stocks to short when a COVID vaccine is ready, says JPMorgan (MarketWatch)
  12. Oil Production Cuts Could Be Extended: Putin (ZeroHedge)
  13. Does Intel Deserve More Credit For Q3 Earnings? (24/7 Wall Street)
  14. Copper’s ‘unignorable’ strength is saying bullish things about the economy (MarketWatch)
  15. European equities rise on upbeat earnings (Financial Times)